Erich Stoelben

Papers

Total Citations

H-Index

About

Dr. Erich Stoelben is a leading thoracic surgeon whose research has significantly advanced the treatment of early-stage lung cancer, particularly for patients who are not candidates for traditional surgery. His work centers on the intersection of minimally invasive surgical techniques and high-precision radiation oncology, with a major focus on risk-adapted stereotactic body radiation therapy (SBRT). In his highly cited 2017 study, "Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer," Dr. Stoelben demonstrated how robotic SBRT can be tailored to individual patient risk profiles, achieving excellent local control while minimizing toxicity—a pivotal contribution that has helped establish SBRT as a standard option for inoperable disease. With over 36 citations, this work underscores his impact on clinical practice. Beyond this, Dr. Stoelben has been instrumental in refining surgical approaches for lung cancer, including video-assisted thoracoscopic surgery (VATS) and segmentectomy, and has contributed to guidelines on multimodal therapy. His research consistently bridges the gap between surgical innovation and radiation oncology, offering patients safer, more effective, and less invasive treatment pathways.